Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 06, 2026
Upperton Pharma Solutions has introduced a new brand identity at CPHI Milan, reflecting its expansion into a contract development and manufacturing organization offering services from formulation development through commercial production.
read more
Tuesday, October 06, 2026
Curia plans to invest $28 million to expand sterile active pharmaceutical ingredient manufacturing at its Valladolid, Spain, facility. The project will cover steroid and non-steroid products and is scheduled for completion in the fourth quarter of ...
read more
Tuesday, October 06, 2026
Agilent Technologies is adding laboratory space in Boulder, Colorado, to develop and scale up manufacturing technologies for oligonucleotide therapeutics, with an initial focus on enzymatic ligation.
read more
Tuesday, October 13, 2026
Southern Research has received an $8 million National Institutes of Health grant to build a shared-use biomedical research facility focused on developing and validating methods that reduce reliance on animal testing in drug discovery and development.
read more
Tuesday, October 13, 2026
Scinai Immunotherapeutics has signed a development and clinical manufacturing agreement carrying approximately $5.1 million in committed base service fees with a U.S.-based, Nasdaq-listed biopharmaceutical company.
read more
Tuesday, October 13, 2026
Catalent has signed a commercial supply agreement with consumer health company Mantra to develop, manufacture and package single-serve oral gels for over-the-counter use. The agreement covers products for occasional sleeplessness, pain relief and ...
read more
Tuesday, October 13, 2026
Lonza has signed an exclusive license agreement with Qurient to use the Korean biotechnology company’s cyclin-dependent kinase 7 inhibitors in dual-payload antibody-drug conjugates, adding a new technology to its cancer drug development and ...
read more
Thursday, October 15, 2026
Genezen and Galibra Neuroscience have entered a manufacturing partnership to prepare Galibra’s experimental gene therapy for succinic semialdehyde dehydrogenase deficiency for a planned first human trial.
read more
Thursday, October 15, 2026
Charles River Laboratories has agreed to provide testing and development services to Magellan Stem Cells as the Australian biotechnology company prepares a Phase III program for its experimental osteoarthritis treatment, Zelestrocel. Financial terms ...
read more
Thursday, October 15, 2026
Perceptive Discovery and Nucleus RadioPharma have formed a nonexclusive partnership linking preclinical testing with clinical manufacturing for radiopharmaceutical developers.
read more
Thursday, October 15, 2026
Lonza has expanded its development and manufacturing offering to include more complex biologic medicines, with a stated goal of preparing some programs for Investigational New Drug applications in as little as six months.
read more
Tuesday, October 20, 2026
Fortrea has completed its acquisition of Worldwide Clinical Trials’ Early Phase Services division for approximately $45 million in cash, adding clinical research and laboratory facilities in Texas.
read more
Tuesday, October 20, 2026
Recipharm has added pilot-scale manufacturing for high-potency medicines at its Leganés site in Spain, extending the facility’s capabilities from development through clinical production and commercial supply.
read more
Tuesday, October 20, 2026
AstraZeneca and Oracle Health and Life Sciences have announced a collaboration to test artificial intelligence tools for clinical trial recruitment, earlier diagnosis and drug safety monitoring, beginning with a hypertension program in Abu Dhabi.
read more
Tuesday, October 20, 2026
Kindeva’s Meridian Medical Technologies division has received a Defense Logistics Agency contract worth up to $226 million to supply nerve agent antidote autoinjectors for U.S. military use, the company announced Oct. 15.
read more